CQDM, the Quebec Breast Most cancers Basis and Theratechnologies fund near $2 million for analysis undertaking to validate the anti-metastatic potential of TH1902 on the Université du Québec à Montréal

[ad_1] This part is Partnership Content material provided The content material on this part is provided by GlobeNewswire for the needs of distributing press releases on behalf of its purchasers. Postmedia has not reviewed the content material. by GlobeNewswire Breadcrumb Path Hyperlinks GlobeNewswire Creator of the article: Article content material MONTREAL, July 12, 2022 (GLOBE … Read more